Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Kyowa Hakko Kirin Company, Limited

ClinicalTrials.gov Identifier:

NCT00364468

First received: August 14, 2006

Last updated: August 23, 2012

Last verified: August 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	March 2008 (Final data collection date for primary outcome measure)